embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes
September 03, 2024 06:30 ET
|
Embecta Corp.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
June 24, 2024 06:30 ET
|
Embecta Corp.
embecta-sponsored abstracts presented at ADA's 84th Scientific Sessions highlight unmet need for patch pumps with 300u insulin reservoir
Global Insulin Delivery Systems Strategic Research Report 2024-2030 - Constantly Expanding R&D Activities and New Pioneering Treatments Influence Growth
May 21, 2024 05:44 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Insulin Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Insulin Delivery Systems...
Comprehensive Market Analysis Reveals Significant Insights into the Insulin Pumps and Continuous Glucose Monitors Market Through 2033
April 03, 2024 12:04 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Insulin Pumps and Continuous Glucose Monitors Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033" report has been added...
Global Wearable Injectors Market Analysis & Forecast 2024-2034: Oncology Applications Reigned in 2023, While Infectious Disease Applications Surge with Highest CAGR Amid Emerging Health Challenges
January 24, 2024 14:25 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Wearable Injectors Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
embecta Announces FDA 510(k) Submission for Insulin Patch Pump
January 09, 2024 06:00 ET
|
Embecta Corp.
embecta has submitted a 510(k) premarket filing to the FDA for a proprietary disposable insulin delivery system.
Major Players in the Insulin Patch Pumps Global Market to 2030 Include Callnovo, Medtronic, Ypsomed, Sanofi and More
September 26, 2023 06:03 ET
|
Research and Markets
Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The "Insulin Patch Pumps Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the insulin patch pumps...
Rising Demand for Large Volume Wearable Injectors: Insights from Market Trends, Partnerships, and Growing Therapeutic Applications in Chronic Diseases
September 01, 2023 11:09 ET
|
Research and Markets
Dublin, Sept. 01, 2023 (GLOBE NEWSWIRE) -- The "Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability,...
Global Insulin Patch Pump Market Report 2023: Integration of Advanced Technologies Drives Growth
June 08, 2023 10:43 ET
|
Research and Markets
Dublin, June 08, 2023 (GLOBE NEWSWIRE) -- The "Global Insulin Patch Pump Market 2023-2030" report has been added to ResearchAndMarkets.com's offering.According to a recent study conducted by the...
United Arab Emirates Insulin Pumps Markets Report 2023-2027 Featuring Major Players - Medtronic, Roche, Abbott Laboratories, Nipro, B. Braun Medical, Terumo, & Becton, Dickinson, and Company
March 30, 2023 10:38 ET
|
Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "UAE Insulin Pumps Market, By Type (Traditional Insulin Pumps v/s Patch Pumps), By Insulin Used (Short Acting Insulin v/s Rapid Acting Insulin), By...